Table 1.
Characteristic | No CI-AKI | CI-AKI | CI-AKI (S1) | CI-AKI (S2) | P value |
---|---|---|---|---|---|
Number of subject |
114 |
16 |
13 |
3 |
|
CKD stage III: CKD stage IV |
90:24 |
10:6 |
9:4 |
1:2 |
|
Age (yr) |
70 ± 10 |
72 ± 7 |
73 ± 5 |
70 ± 9 |
0.67 |
Men: women |
88:26 |
12:4 |
10:3 |
2:1 |
0.17 |
SBP (mmHg) |
129 ± 17 |
125 ± 13 |
125 ± 14 |
124 ± 14 |
0.65 |
DBP(mmHg) |
71 ± 10 |
69 ± 12 |
70 ± 12 |
67 ± 8 |
0.74 |
Heart rate |
75 ± 10 |
74 ± 12 |
76 ± 11 |
72 ± 8 |
0.48 |
Height (cm) |
162 ± 9 |
161 ± 9 |
160 ± 7 |
162 ± 8 |
0.85 |
Weight (kg) |
60 ± 13 |
56 ± 7 |
58 ± 5 |
54 ± 8 |
0.16 |
Body mass index (kg/m2) |
24 ± 4 |
23 ± 3 |
23 ± 3 |
21 ± 4 |
0.14 |
Diabetes mellitus (%) |
42 |
44 |
46 |
33 |
0.25 |
Hypertension (%) |
80 |
75 |
77 |
67 |
0.19 |
Hypercholesterolemia (%) |
50 |
44 |
38 |
67 |
0.16 |
Myocardial infarction (%) |
18 |
25 |
23 |
33 |
0.37 |
LVEF < 40% (%) |
20 |
19 |
15 |
33 |
0.59 |
CCS > II (%) |
96 |
94 |
92 |
100 |
0.49 |
NYHA > II (%) |
44 |
44 |
38 |
67 |
0.6 |
Angiogram/PCI (%) |
66 |
75 |
85 |
67 |
0.58 |
Number of vessel disease > 1 (%) |
61 |
63 |
50 |
67 |
0.62 |
ACEI (%) |
30 |
31 |
31 |
33 |
0.42 |
ATRA (%) |
40 |
31 |
31 |
33 |
0.48 |
Beta blocker (%) |
54 |
44 |
38 |
67 |
0.56 |
CCB (%) |
28 |
31 |
31 |
33 |
0.26 |
Diuretic (%) |
26 |
31 |
31 |
33 |
0.64 |
Aspirin (%) |
72 |
63 |
62 |
67 |
0.51 |
Statin (%) |
48 |
44 |
38 |
67 |
0.17 |
Nitrate (%) |
38 |
38 |
31 |
67 |
0.14 |
Contrast volume (ml) |
126 ± 65 |
129 ± 90 |
126 ± 80 |
124 ± 92 |
0.43 |
IV volume (ml) |
1483 ± 453 |
1591 ± 260 |
1598 ± 246 |
1562 ± 128 |
0.48 |
Total risk score | 8 ± 3 | 8 ± 3 | 8 ± 3 | 9 ± 1 | 0.24 |
CI-AKI indicates contrast induced acute kidney injury, CI-AKI (S1) indicates CI-AKI stage I, CI-AKI (S2) indicates CI-AKI stage II, SBP indicates systolic blood pressure, DBP indicates diastolic blood pressure, LVEF indicates left ventricular ejection fraction, CCS indicates Canadian Cardiovascular Society, NYHA indicates New York Heart Association, PCI indicates percutaneous intervention, CCB indicates calcium channel blocker.